Phase 1 Cerebrovascular Disease Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1
Inhaled Nitric Oxide in Acute Ischemic Stroke Patients Undergoing Mechanical Thrombectomy
Cerebrovascular DisordersAcute Cerebrovascular Disease
Wake Forest University Health Sciences36 enrolled2 locationsNCT05871606
Recruiting
Phase 1Phase 2
Rifaximin SSD in Dementia Trial
Dementia Alzheimer TypeDementia Associated With Cerebrovascular Disease
Jasmohan Bajaj20 enrolled1 locationNCT06718686